Wong, A. C., Pitroda, S., Watson, S., Son, C., Das, L. C., Uppal, A., … Chmura, S. J. (2015). Long-term Survivors of an SBRT Dose-Escalation Study for Oligometastases: Clinical and Molecular Markers. In International Journal of Radiation Oncology*Biology*Physics (Vol. 93, pp. S64–S64). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2015.07.152

Wong, A. C., S. Pitroda, S. Watson, C. Son, L. C. Das, A. Uppal, G. Oshima, et al. “Long-term Survivors of an SBRT Dose-Escalation Study for Oligometastases: Clinical and Molecular Markers.” In International Journal of Radiation Oncology*Biology*Physics, 93:S64–S64. Elsevier BV, 2015. https://doi.org/10.1016/j.ijrobp.2015.07.152.

Wong AC, Pitroda S, Watson S, Son C, Das LC, Uppal A, et al. Long-term Survivors of an SBRT Dose-Escalation Study for Oligometastases: Clinical and Molecular Markers. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015. p. S64–S64.

Wong, A. C., et al. “Long-term Survivors of an SBRT Dose-Escalation Study for Oligometastases: Clinical and Molecular Markers.” International Journal of Radiation Oncology*Biology*Physics, vol. 93, no. 3, Elsevier BV, 2015, pp. S64–S64. Crossref, doi:10.1016/j.ijrobp.2015.07.152.

Wong AC, Pitroda S, Watson S, Son C, Das LC, Uppal A, Oshima G, Stack M, Khodarev N, Salama JK, Posner M, Weichselbaum RR, Chmura SJ. Long-term Survivors of an SBRT Dose-Escalation Study for Oligometastases: Clinical and Molecular Markers. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015. p. S64–S64.